Description

This issue of Vital Signs, released on October 6, 2008, provides an strategic overview issues and trends in personalized testing. Additionally, a company spotlight is provided for Genoptix, a leading laboratory services provider delivering comprehensive and personalized diagnostic services to community hematologists and oncologists. Reimbursement and regulatory news from the FDA is also provided for the week of September 22, 2008.